BR0312889A - Polipeptìdeo t20 peguilado - Google Patents

Polipeptìdeo t20 peguilado

Info

Publication number
BR0312889A
BR0312889A BR0312889-0A BR0312889A BR0312889A BR 0312889 A BR0312889 A BR 0312889A BR 0312889 A BR0312889 A BR 0312889A BR 0312889 A BR0312889 A BR 0312889A
Authority
BR
Brazil
Prior art keywords
polypeptide
pegged
compounds
pegylated
polypeptide compounds
Prior art date
Application number
BR0312889-0A
Other languages
English (en)
Inventor
Pascal Sebastian Bailon
Chee-Youb Won
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR0312889A publication Critical patent/BR0312889A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16—HIV-1 ; HIV-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"POLIPEPTìDEO T20 PEGUILADO". Compostos de polipeptídeo T20 peguilado são providos. São também providas composições farmacêuticas contendo compostos de polipeptídeo T20 peguilado e processos de fabricação e uso de tais compostos e composições.
BR0312889-0A 2002-07-24 2003-07-16 Polipeptìdeo t20 peguilado BR0312889A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39819502P 2002-07-24 2002-07-24
PCT/EP2003/007710 WO2004013164A1 (en) 2002-07-24 2003-07-16 Pegylated t20 polypeptide

Publications (1)

Publication Number Publication Date
BR0312889A true BR0312889A (pt) 2005-06-14

Family

ID=31495720

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312889-0A BR0312889A (pt) 2002-07-24 2003-07-16 Polipeptìdeo t20 peguilado

Country Status (24)

Country Link
US (1) US7049415B2 (pt)
EP (1) EP1527088B1 (pt)
JP (1) JP4381301B2 (pt)
KR (1) KR100637981B1 (pt)
CN (1) CN100357317C (pt)
AR (1) AR040651A1 (pt)
AT (1) ATE489401T1 (pt)
AU (1) AU2003257467B2 (pt)
BR (1) BR0312889A (pt)
CA (1) CA2493534C (pt)
DE (1) DE60335111D1 (pt)
ES (1) ES2354609T3 (pt)
GT (1) GT200300155A (pt)
HR (1) HRP20050024A2 (pt)
IL (2) IL166038A0 (pt)
MX (1) MXPA05000797A (pt)
NO (1) NO20050066L (pt)
PA (1) PA8577701A1 (pt)
PE (1) PE20040705A1 (pt)
PL (1) PL375254A1 (pt)
RU (1) RU2296769C2 (pt)
TW (1) TW200416225A (pt)
WO (1) WO2004013164A1 (pt)
ZA (1) ZA200500258B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
PT2311432E (pt) 2002-06-07 2015-02-09 Dyax Corp Polipeptídeos de domínio kunitz modificado e sua utilização para a redução de isquemia ou aparecimento de uma resposta inflamatória sistémica associada a um procedimento cirúrgico
US20070020252A1 (en) * 2003-08-29 2007-01-25 Ladner Robert C Modified protease inhibitors
WO2005021557A2 (en) * 2003-08-29 2005-03-10 Dyax Corp. Poly-pegylated protease inhibitors
CN101132812A (zh) * 2004-03-15 2008-02-27 阿拉巴马耐科塔医药公司 Hiv进入抑制剂的聚合物基组合物和结合物
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
PT1869066E (pt) * 2005-04-08 2010-02-03 Lonza Ag Síntese de peptídeo de hélice-alfa sobre resina peg
WO2009026334A2 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
AU2010203712A1 (en) 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
LT2521568T (lt) 2010-01-06 2018-12-10 Dyax Corp. Plazmos kalikreiną surišantys baltymai
CN105713092B (zh) 2011-01-06 2019-09-10 戴埃克斯有限公司 血浆前激肽释放酶结合蛋白
KR102555955B1 (ko) 2014-03-27 2023-07-18 다케다 파머수티컬 컴패니 리미티드 당뇨병성 황반 부종의 치료를 위한 조성물 및 방법
US20160151511A1 (en) 2014-12-02 2016-06-02 Antriabio, Inc. Proteins and protein conjugates with increased hydrophobicity
AU2016366557B2 (en) 2015-12-11 2024-01-25 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US153694A (en) * 1874-08-04 Improvement in clothes-pounders
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
CH690143A5 (de) * 1995-01-27 2000-05-15 Rieter Automotive Int Ag Lambda/4-Schallabsorber.
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US5990237A (en) * 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
DE69926061T2 (de) * 1998-03-23 2006-06-01 Trimeris Inc. Verfahren und zusammensetzungen zur peptidsynthese (t-20)
EP1135493A2 (en) * 1998-11-30 2001-09-26 Eli Lilly And Company Erythropoietic compounds
PE20010288A1 (es) * 1999-07-02 2001-03-07 Hoffmann La Roche Derivados de eritropoyetina
KR100488351B1 (ko) * 2001-12-11 2005-05-11 선바이오(주) 신규한 폴리에틸렌글리콜-프로피온알데히드 유도체

Also Published As

Publication number Publication date
PL375254A1 (en) 2005-11-28
TW200416225A (en) 2004-09-01
KR20050027257A (ko) 2005-03-18
ZA200500258B (en) 2006-01-25
CA2493534A1 (en) 2004-02-12
JP4381301B2 (ja) 2009-12-09
IL166038A (en) 2010-11-30
MXPA05000797A (es) 2005-04-19
ATE489401T1 (de) 2010-12-15
CA2493534C (en) 2010-01-26
PA8577701A1 (es) 2004-02-07
AR040651A1 (es) 2005-04-13
IL166038A0 (en) 2006-01-15
HRP20050024A2 (en) 2006-02-28
AU2003257467B2 (en) 2008-02-28
JP2006511455A (ja) 2006-04-06
AU2003257467A1 (en) 2004-02-23
GT200300155A (es) 2004-03-15
RU2296769C2 (ru) 2007-04-10
ES2354609T3 (es) 2011-03-16
EP1527088B1 (en) 2010-11-24
RU2005105577A (ru) 2005-10-27
KR100637981B1 (ko) 2006-10-23
PE20040705A1 (es) 2004-10-14
NO20050066L (no) 2005-04-22
US20040049018A1 (en) 2004-03-11
CN100357317C (zh) 2007-12-26
WO2004013164A1 (en) 2004-02-12
CN1671736A (zh) 2005-09-21
EP1527088A1 (en) 2005-05-04
DE60335111D1 (de) 2011-01-05
US7049415B2 (en) 2006-05-23

Similar Documents

Publication Publication Date Title
NO20050066L (no) Pegylert T20 polypeptid
NO952744D0 (no) Cytokinbegrensende midler
ATE271058T1 (de) Mycophenol bisphosponatverbindungen
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
PL366198A1 (en) Novel compounds
DK1025124T3 (da) Human interferon-alfa-analoge med lav toksicitet
EP1093372A4 (en) CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS OF INHIBITING PEPTIDE RELEASE $ g (b) -AMYLOID AND / OR ITS SYNTHESIS USING THE SAME
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
BR9714358A (pt) Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
SE9300012D0 (sv) New peptides
NO20073914L (no) Biologisk aktive peptider
SE0101038D0 (sv) Novel compounds
ATE497967T1 (de) Interzelluläre kommunikation erleichternden verbindungen und deren medizinischen verwendungen
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
TR200103240T2 (tr) Endoparazit öldürücü bileşimler.
EA200100069A1 (ru) Новые 19-норстероиды, галогенированные в положении 17, способ их получения и их применение, промежуточные продукты и фармацевтические композиции, их содержащие
ITMI922332A1 (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale.
TW200611913A (en) Biologically active peptides (Ⅲ)
UY27901A1 (es) Polipeptido t20 pegilado
JO1711B1 (en) Therapeutic agents
MY134618A (en) Filarial parasite polypeptides and sequences, gene sequences and uses thereof

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]